tHEORetically Speaking: Meeting the Resource Challenge - Why Biotechs Need a Different Kind of Partner

In this episode of Theoretically Speaking, Paige McGarry interviews David W. Miller, CEO of Genesis Research Group, discussing the unique challenges faced by biotech companies in evidence generation, market access, and stakeholder engagement.

David W. Miller discusses how Genesis Research Group addresses these challenges, including the importance of demonstrating value early in development, the role of real-world evidence in supporting biotechs, and how to navigate uncertainty in the biotech landscape. Additionally, strategies for effective data collection are introduced, while emphasizing the need for flexibility and adaptability in the ever-evolving life sciences sector.  Genesis Research Group's Flexible Integrated Team (FIT) model is also discussed as an adaptable and fit-for-purpose program to support biotechs, ensuring development and launch are optimized, regardless of size, resources, and specific needs. Representing a true paradigm shift in strategic partnerships, David explains how the Genesis team is able to adapt their extensive global expertise in areas such as pricing, real-world evidence, HEOR, and market access as they support emerging biotechs to ensure commercial success.

For more information or to access other resources, click here.

Introducing Trial Insights—the essential tool for pharma researchers and biotech investors. 

Seamlessly track clinical trials in real-time, refine searches by key criteria, and receive timely notifications on important updates. With Trial Insights, ensure your research and business initiatives are always informed and strategically positioned for success. 

Start exploring thousands of trials today at trialinsights.com